摘要
目的:评价联合美常安治疗溃疡性结肠炎 (UC)的疗效．方法:轻、中度活动期UC患者46例,随机分为美常安加柳氮磺吡啶(SASP)治疗组(n=22) 和SASP对照组(n=24),评价治疗前后总的疗效、主要症状的变化．结果:治疗组总有效率为91．66％,明显高于对照组(总有效率为68．18％);腹痛、腹泻、黏液血便、里急后重主要症状变化的比较二组间有统计学意义(P<0．05)．结论:联合美常安治疗溃疡性结肠炎比单用 SASP疗效好．
AIM： To evaluate the therapeutic effect of Medilac-S combined with sulfasalazine （SASP） in the treatment of ulcerative colitis （UC）.
METHODS： Forty-six patients with mild or moderate UC （active phase） were divided into group A （n = 22） and B （n = 24）. The patients in group A were treated with Medilac-S and SASP, while those in group B, serving as the controls, were treated with SASP. The total efficacy rate and the changes of main symptoms were statistically analyzed.
RESULTS： The overall efficacy of group A was 91.66%, which was higher than that of the controis （68.18%, P 〈 0.05）. There was significant difference before and after treatment, as well as between the two groups （P 〈 0.05） in the changes of abdominal pain, diarrhea, mucus bloody stool and tenesmus （P 〈 0.05）.
CONCLUSION： Combination of Medilac-S and SASP is superior to SASP alone in the treatment of UC.
出处
《世界华人消化杂志》
CAS
北大核心
2006年第17期1742-1744,共3页
World Chinese Journal of Digestology
关键词
溃疡性结肠炎
美常安
治疗
Ulcerative Colitis
Medilac-S
Treatment
